HAMPSHIRE-based Genetix Group, which specialises in genomics and proteomics technology has appointed Jim Bull as head of North American sales.

Mr Bull has 25 years' experience of selling products and services within the life sciences industry.

Mark Reid, chief executive officer of the New Milton firm, said: "The US market already accounts for 52 per cent of sales and Genetix is committed to strengthening our US presence further. We opened our US headquarters in Boston last year and plan further appointments to boost the US team over coming months. Jim has invaluable experience and contacts and a broad knowledge of the market."